Synovial Sarcoma
Synonyms: Synovial cell sarcoma
t(X;18) EWSR1-SS18 fusion diagnostic
Quick Facts
Behaviour
Malignant
Category
Soft tissue
Grade
High
Synonyms
Synovial cell sarcoma
Category
Soft tissue
Behaviour
Malignant
Grade
High
Gender
Both equally
Tissue of Origin
Other
Epidemiology
- Malignant sarcoma affecting adolescents and young adults
- Peak incidence 2nd-3rd decades
- Predilection for extremities
- Monoarticular near large joints
- t(X;18) EWSR1-SS18 translocation diagnostic
Clinical Features
- Painful mass near large joint
- Rapid growth
- Limited joint motion
- Constitutional symptoms if metastatic
Location
- Knee (most common)
- Ankle
- Shoulder
- Elbow
- Wrist
Imaging
- MRI: heterogeneous mass near joint
- T2: cystic areas and hemorrhage common
- Calcification rare but characteristic
Pathology
- Biphasic (epithelial + spindle) or monophasic variants
- t(X;18) EWSR1-SS18 fusion pathognomonic
- SS18+ (nuclear immunostain)
- High-grade sarcoma
Genetics
- t(X;18)(p11;q11) EWSR1-SS18 90%
- t(X;18)(p11;q11) EWSR1-SSX2 5-10%
- Rare other rearrangements
Treatment
- Wide surgical resection: primary treatment
- Chemotherapy: neoadjuvant or adjuvant
- Radiotherapy: adjuvant if margins inadequate
Prognosis
- 60-70% 5-year survival with multimodal therapy
- Stage and size prognostic factors
- High metastatic potential
Key Points
- t(X;18) EWSR1-SS18 fusion diagnostic
- Multimodal therapy standard
- High-grade malignancy despite small appearance
Workup - Blood Tests
FBC, U&E, LFTs, LDH
Workup - Local Imaging
- MRI primary site: local staging
- CT chest/abdomen/pelvis: metastatic staging
- PET-CT: consider
Workup - Biopsy
Core needle biopsy: EWSR1-SS18 FISH confirmatory
Workup - Staging
CT chest/abdomen/pelvis: standard
Follow-up Summary
- Year 1: Post-operative visit within first 6 weeks; 3–4 monthly clinical examination and CXR; image prosthesis at 6 months and 1 year
- Year 2: 3–4 monthly clinical examination and CXR; image prosthesis annually
- Years 3–4: 6-monthly clinical examination and CXR; image prosthesis annually
- Years 5–10: Annual clinical examination and CXR; image prosthesis annually
- Discharge at 10 years after treatment